Etherified CMC Wound Healing Composition for Tissue Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Chronic wounds and non-healing tissue damage pose significant challenges in healthcare, particularly for bedridden or diabetic patients, with limited tissue regeneration and increased risk of infection and inflammation.
Innovation Solution
A biocompatible etherified sodium carboxymethyl cellulose (CMC) composition, known as BloodSTOP iX Wound Heal (BSiX), modulates growth factors like VEGF and PDGF to promote tissue regeneration, inhibits inflammatory cytokines, and provides a scaffold for cellular infiltration and capillary growth.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional wound care materials are used, then basic wound coverage is provided, but tissue regeneration is limited and healing is slow
Solution Approach 1:
The patent uses etherified sodium carboxymethyl cellulose (CMC) as a composite material that combines hemostatic, anti-inflammatory, and tissue regeneration properties. This composite material approach resolves the contradiction by integrating multiple functional capabilities into a single wound care product, enabling both rapid healing and reliable tissue regeneration simultaneously.
Solution Approach 2:
The patent modifies the chemical structure of CMC through etherification to enhance its biological activity. By changing the chemical parameters of the material (adding ether groups), the material gains improved ability to modulate growth factors and cytokines, thereby achieving both faster healing and better tissue regeneration outcomes.
2Productivity
If growth factors are stimulated to promote tissue regeneration, then healing is accelerated, but inflammatory response and infection risk increase
Solution Approach 1:
The patent converts the harmful inflammatory response into a beneficial effect by using the etherified CMC material to modulate cytokine production. The material stimulates protective cytokines while controlling excessive inflammation, thereby transforming the potentially harmful inflammatory process into a controlled, beneficial response that supports tissue regeneration without increasing infection risk.
Solution Approach 2:
The etherified CMC material acts as an intermediary between the wound environment and the immune response. It mediates the interaction by binding to and modulating cytokines and growth factors, thereby regulating the inflammatory response and preventing excessive inflammation while still allowing necessary immune functions to occur.
3Productivity
If advanced tissue regeneration materials are used, then healing efficiency is improved, but material complexity and cost increase
Solution Approach 1:
The etherified CMC material is designed to perform multiple functions simultaneously: hemostasis, anti-inflammatory action, growth factor modulation, and tissue regeneration support. This multi-functionality approach resolves the contradiction by providing advanced healing efficiency through a single material rather than requiring complex combinations of multiple materials, thereby reducing overall system complexity.
Data Source
AI summary
The invention provides novel compositions and methods for tissue growth factor regulation for healing and tissue regeneration, and methods for their preparation and use.